1-7 of 7
Daniel Pollyea, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization and Targeting of Myelodysplastic Syndrome Stem Cells

Brett M Stevens, PhD, Daniel Pollyea, MD MS, Nabilah Khan, PhD, Craig T Jordan, PhD
Journal: Blood
Blood (2015) 126 (23): 4104.
https://doi.org/10.1182/blood.V126.23.4104.4104
Published: 2015
Journal Articles

Regulation of Mitochondrial Morphology Is Important for Leukemia Stem Cell Function

Shanshan Pei, PhD, Mohammad Minhajuddin, PhD, Brett M Stevens, PhD, Biniam Adane, Nabilah Khan, PhD, Angelo D'alessandro, PhD, Travis Nemkov, Kirk C Hansen, PhD, Daniel Pollyea, MD MS, Craig T Jordan, PhD
Journal: Blood
Blood (2015) 126 (23): 842.
https://doi.org/10.1182/blood.V126.23.842.842
Published: 2015
Journal Articles

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Zohra Nooruddin, MD, William Robinson, MD PhD, Daniel Pollyea, MD MS, Jonathan A Gutman, MD, Clayton Smith, MD FRCPC, Zenggang Pan, MD, Craig T Jordan, PhD, Rachel Rabinovitch, MD, Jeffrey Schowinsky, Xian Lu, PhD, Douglas Ney, MD, Manali Kamdar, MD
Journal: Blood
Blood (2015) 126 (23): 1443.
https://doi.org/10.1182/blood.V126.23.1443.1443
Published: 2015
Journal Articles

Meningeoma-1 Cooperates with MLL and DOT1L to Induce Leukemia

Simone Riedel, PhD, Jessica Haladyna, BA, Brett Stevens, Craig T Jordan, PhD, Daniel Pollyea, MD MS, Scott A. Armstrong, MD PhD, Qi Wei, PhD, Patricia Ernst, PhD, Tobias Neff, MD, Kathrin M Bernt, MD
Journal: Blood
Blood (2015) 126 (23): 2428.
https://doi.org/10.1182/blood.V126.23.2428.2428
Published: 2015
Journal Articles

A Phase 1b Study of Venetoclax (ABT-199/GDC-0199) in Combination with Decitabine or Azacitidine in Treatment-Naive Patients with Acute Myelogenous Leukemia Who Are ≥ to 65 Years and Not Eligible for Standard Induction Therapy

Courtney DiNardo, MD, Daniel Pollyea, MD MS, Keith Pratz, MD, Michael J. Thirman, MD, Anthony Letai, MD PhD, Mark Frattini, MD PhD, Brian Jonas, MDPhD, Joel Leverson, PhD, Ming Zhu, PhD, Martin Dunbar, DrPH, Nancy Falotico, Rachel Kirby, BA, Suresh Agarwal, PhD, Mack Mabry, MD, Jalaja Potluri, MD, Rod A. Humerickhouse, MD PhD, Hagop M. Kantarjian, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 327.
https://doi.org/10.1182/blood.V126.23.327.327
Published: 2015
Journal Articles

Safety and Efficacy of AG-221, a Potent Inhibitor of Mutant IDH2 That Promotes Differentiation of Myeloid Cells in Patients with Advanced Hematologic Malignancies: Results of a Phase 1/2 Trial

Eytan M. Stein, MD, Courtney DiNardo, MD, Jessica K. Altman, MD, Robert Collins, MD, Daniel J. DeAngelo, MD PhD, Hagop M. Kantarjian, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Ian W. Flinn, MD PhD, Arthur E. Frankel, MD, Ross L. Levine, MD, Bruno C. Medeiros, MD, Manish R. Patel, MD, Daniel Pollyea, MD MS, Gail J. Roboz, MD, Richard M. Stone, MD, Ronan T. Swords, MDPhDFRCPI FRCPath, Martin S. Tallman, MD, Katherine Yen, PhD, Eyal C. Attar, MD, Qiang Xu, PhD, Alessandra Tosolini, BS, Jay M. Mei, MD PhD, Anjan Thakurta, Robert D. Knight, MD, Stéphane De Botton, MD PhD
Journal: Blood
Blood (2015) 126 (23): 323.
https://doi.org/10.1182/blood.V126.23.323.323
Published: 2015
Journal Articles

Biomarkers To Predict Outcome after Allogeneic Hematopoietic Cell Transplant (HCT).

Shira N. Dinner, MD, Andrew Artz, MD, MS, Masha Kocherginsky, PhD, Jodie Ulaszek, MS, Daniel Pollyea, MD, Lucy Godley, MD, PhD, Richard A. Larson, MD, Olatoysi Odenike, MD, Elizabeth Rich, MD, PhD, Wendy Stock, MD, Koen van Besien, MD, Amittha Wickrema, PhD
Journal: Blood
Blood (2007) 110 (11): 1100.
https://doi.org/10.1182/blood.V110.11.1100.1100
Published: 2007